FCBSX
Price
$35.75
Change
-$0.28 (-0.78%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

FCBSX vs VMVAX

Header iconFCBSX vs VMVAX Comparison
Open Charts FCBSX vs VMVAXBanner chart's image
Franklin Mutual U.S. Mid Cap Value C
Price$35.75
Change-$0.28 (-0.78%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FCBSX vs VMVAX Comparison Chart
Loading...
VS
FCBSX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCBSX is a Buy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. FCBSX (814M). VMVAX pays higher dividends than FCBSX: VMVAX (2.14) vs FCBSX (0.35). FCBSX was incepted earlier than VMVAX: FCBSX (24 years) vs VMVAX (13 years). FCBSX is a more actively managed with annual turnover of: 64.21 vs. VMVAX (22.00). FCBSX has a lower initial minimum investment than VMVAX: FCBSX (1000) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. FCBSX (19.37). VMVAX return over 5 years is better than : 48.82 vs. FCBSX (11.13).
FCBSXVMVAXFCBSX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years13 years-
Gain YTD10.81814.94672%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets814M30.5B3%
Annual Yield % from dividends0.352.1416%
Returns for 1 year19.3725.3576%
Returns for 3 years-0.0920.71-0%
Returns for 5 years11.1348.8223%
Returns for 10 years-28.75100.88-28%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio